Jafron Biomedical Co.,Ltd. Stock
Equities
300529
CNE100002995
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.16 CNY | -1.51% | -3.19% | -0.31% |
Sales 2023 * | 2B 277M | Sales 2024 * | 2.52B 348M | Capitalization | 17.7B 2.44B |
---|---|---|---|---|---|
Net income 2023 * | 591M 81.63M | Net income 2024 * | 775M 107M | EV / Sales 2023 * | 8.83 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 7.03 x |
P/E ratio 2023 * |
30.4
x | P/E ratio 2024 * |
23.2
x | Employees | 3,003 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 47.08% |
1 day | -1.51% | ||
1 week | -3.19% | ||
Current month | -0.31% | ||
1 month | -6.10% | ||
3 months | +14.70% | ||
6 months | +3.07% | ||
Current year | -0.31% |
Managers | Title | Age | Since |
---|---|---|---|
Fan Dong
CEO | Chief Executive Officer | 54 | 98-12-31 |
Yao Hong Chen
BRD | Director/Board Member | 45 | 12-12-31 |
Feng Li
BRD | Director/Board Member | 54 | 09-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Guo Qing Guo
BRD | Director/Board Member | 62 | 23-04-20 |
Yan Jun Xu
BRD | Director/Board Member | 51 | 23-04-20 |
Fan Dong
CEO | Chief Executive Officer | 54 | 98-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.44% | 2 M€ | -20.87% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 22.16 | -1.51% | 5,022,557 |
24-04-18 | 22.5 | -1.53% | 4,277,793 |
24-04-17 | 22.85 | -0.22% | 6,771,052 |
24-04-16 | 22.9 | -0.87% | 5,694,978 |
24-04-15 | 23.1 | +0.92% | 6,488,661 |
End-of-day quote Shenzhen S.E., April 18, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.31% | 2.48B | |
-2.53% | 183B | |
-3.52% | 105B | |
+5.33% | 51.77B | |
+16.43% | 47.29B | |
-1.73% | 40.2B | |
+5.66% | 27.62B | |
-2.01% | 25.51B | |
+9.84% | 24.73B | |
-1.87% | 24.52B |
- Stock Market
- Equities
- 300529 Stock